tradingkey.logo
tradingkey.logo
Suchen

Bone Biologics Corp

BBLGW
Zur Watchlist hinzufügen
15.000USD
0.0000.00%
Handelsschluss 07/07, 16:00ETKurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM

mehr Informationen über Bone Biologics Corp Unternehmen

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corp Informationen

BörsenkürzelBBLGW
Name des UnternehmensBone Biologics Corp
IPO-datumNov 27, 2015
CEOMr. Jeffrey Frelick
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse2 Burlington Woods Dr Ste 100
StadtBURLINGTON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl01803-4551
Telefon17815524452
Websitehttps://www.bonebiologics.com/
BörsenkürzelBBLGW
IPO-datumNov 27, 2015
CEOMr. Jeffrey Frelick

Führungskräfte von Bone Biologics Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Bone Biologics Corp?

Die fünf größten Anteilseigner von Bone Biologics Corp sind: Mr. Jody Cain